Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nymox Pharm Corp (NYMX)

Nymox Pharm Corp (NYMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 139,938
  • Shares Outstanding, K 69,969
  • Annual Sales, $ 300 K
  • Annual Income, $ -10,590 K
  • 60-Month Beta 1.93
  • Price/Sales 461.00
  • Price/Cash Flow N/A
  • Price/Book 23.60

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.69 +18.07%
on 11/19/19
2.09 -4.31%
on 12/11/19
+0.14 (+7.53%)
since 11/11/19
3-Month
1.69 +18.07%
on 11/19/19
2.28 -12.28%
on 10/24/19
+0.18 (+9.89%)
since 09/11/19
52-Week
1.25 +60.00%
on 12/24/18
2.75 -27.27%
on 02/19/19
+0.32 (+19.05%)
since 12/11/18

Most Recent Stories

More News
Nymox: 3Q Earnings Snapshot

ST. LAURENT, Quebec (AP) _ Nymox Pharmaceutical Corp. (NYMX) on Wednesday reported a loss of $2.5 million in its third quarter.

NYMX : 2.00 (+1.52%)
Nymox Reports on Newly Issued Patents and Corporate Developments

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report very positive fundamental news, that the Company has received several new additional United States, European, and other jurisdictional...

NYMX : 2.00 (+1.52%)
Nymox End of Q2 New Investor Presentation on Website

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide an up-to-date investor communication presentation posted on the Nymox website today as the end of second quarter update for shareholders....

NYMX : 2.00 (+1.52%)
Nymox: 1Q Earnings Snapshot

ST. LAURENT, Quebec (AP) _ Nymox Pharmaceutical Corp. (NYMX) on Wednesday reported a loss of $2.9 million in its first quarter.

NYMX : 2.00 (+1.52%)
Nymox Teleconference Monday, March 25 10:00 a.m. EDT

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Nymox will hold a teleconference for shareholders on Monday, March 25 at 10:00 a.m. Eastern Daylight Time (EDT). Management will provide an update on the...

NYMX : 2.00 (+1.52%)
Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC)

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that Mark Staples PhD has joined Nymox as Vice President for Chemistry, Manufacturing, and Controls (CMC). Dr Staples is an expert...

NYMX : 2.00 (+1.52%)
Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the Company's Director of Quality and EU Qualified Person, for all of Nymox's...

NYMX : 2.00 (+1.52%)
Nymox to Host Investor Teleconference

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) will hold a teleconference for shareholders on March 25, 2019.

NYMX : 2.00 (+1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade NYMX with:

Business Summary

Nymox Pharmaceutical Corporation is engaged in the research and development of drugs and diagnostic products. The company offers products such as AlzheimAlert, NicAlert and TobacAlert tests. It markets its products primarily in the United States, Canada, and Europe. Nymox Pharmaceutical Corporation is...

See More

Key Turning Points

2nd Resistance Point 2.17
1st Resistance Point 2.09
Last Price 2.00
1st Support Level 1.92
2nd Support Level 1.84

See More

52-Week High 2.75
Fibonacci 61.8% 2.18
Fibonacci 50% 2.00
Last Price 2.00
Fibonacci 38.2% 1.82
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar